https://www.selleckchem.com/pr....oducts/pd-1-pd-l1-in
are part of the diagnostic differential. Adrenal metastasis was associated with a poor prognosis, with median survival of 8 months. Chest-pain patients with no evidence of acute coronary syndrome might still be at risk for adverse outcomes. Adding renal function to the classic scoring of CHADS and CHA DS VASC may improve risk stratification of chest-pain patients discharged from internal medicine wards after acute coronary syndrome (ACS) rule-out. We accessed medical records of patients admitted to internal medicine wards
Like
Comment
Share
